Skip to main content
Erschienen in: CardioVascular and Interventional Radiology 8/2017

18.05.2017 | Laboratory Investigation

In Vitro Quantification of Luminal Denudation After Crimping and Balloon Dilatation of Endothelialized Covered Stents

verfasst von: Shigeo Ichihashi, Frederic Wolf, Thomas Schmitz-Rode, Kimihiko Kichikawa, Stefan Jockenhoevel, Petra Mela

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Covered stents have been demonstrated to reduce restenosis; however, the membrane’s limited biocompatibility can still lead to thrombus formation. To obtain optimal surface hemocompatibility, endothelialization of the luminal surface has been proposed. However, the effect of delivery procedures, such as crimping and balloon dilatation, on the endothelial layer has not been quantified. This study investigated the impact of such procedures on endothelialized covered stents in vitro.

Methods

Using an injection molding technique, bare metal stents were covered with fibrin subsequently, endothelialized and conditioned in a bioreactor under arterial pressure (80–120 mmHg) and shear stress (1 Pa). For each set of experiments, three covered stents were prepared, one being subjected to crimping alone, one to crimping followed by balloon dilatation and one serving as control. The experiment was repeated three times. The endothelial coverage was quantified by scanning electron microscopy (SEM). The functionality of the endothelium after exposure to platelet-rich plasma was evaluated by immunohistochemistry and SEM.

Results

The mean endothelial coverage of control, crimped, crimped and balloon-dilated stents was 87.6, 80.1 and 52.1%, respectively, indicating that endothelial cells detached significantly not after crimping (P = 0.465) but following balloon dilatation (P < 0.001). The cells present on the stent’s surface, either after crimping or crimping followed by balloon dilatation, expressed eNOS and CD31 and exhibited no platelet adhesion.

Conclusion

The simulated delivery procedure resulted in the retention of viable cells on more than half of the luminal surface. The main damage to the layer occurred during balloon dilatation.
Literatur
1.
Zurück zum Zitat Farhatnia Y, Tan A, Motiwala A, Cousins BG, Seifalian AM. Evolution of covered stents in the contemporary era: clinical application, materials and manufacturing strategies using nanotechnology. Biotechnol Adv. 2013;31:524–42.CrossRefPubMed Farhatnia Y, Tan A, Motiwala A, Cousins BG, Seifalian AM. Evolution of covered stents in the contemporary era: clinical application, materials and manufacturing strategies using nanotechnology. Biotechnol Adv. 2013;31:524–42.CrossRefPubMed
2.
Zurück zum Zitat Kabir AM, Selvarajah A, Seifalian AM. How safe and how good are drug-eluting stents? Future Cardiol. 2011;7:251–70.CrossRefPubMed Kabir AM, Selvarajah A, Seifalian AM. How safe and how good are drug-eluting stents? Future Cardiol. 2011;7:251–70.CrossRefPubMed
3.
Zurück zum Zitat Waksman R. Promise and challenges of bioabsorbable stents. Catheter Cardiovasc Interv. 2007;70:407–14.CrossRefPubMed Waksman R. Promise and challenges of bioabsorbable stents. Catheter Cardiovasc Interv. 2007;70:407–14.CrossRefPubMed
4.
Zurück zum Zitat Aoki J, Serruys PW, van Beusekom H, et al. Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. J Am Coll Cardiol. 2005;45:1574–9.CrossRefPubMed Aoki J, Serruys PW, van Beusekom H, et al. Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. J Am Coll Cardiol. 2005;45:1574–9.CrossRefPubMed
5.
Zurück zum Zitat Saxon RR, Chervu A, Jones PA, et al. Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) trial. J Vasc Interv Radiol. 2013;24:165–73 (quiz 74).CrossRefPubMed Saxon RR, Chervu A, Jones PA, et al. Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) trial. J Vasc Interv Radiol. 2013;24:165–73 (quiz 74).CrossRefPubMed
6.
Zurück zum Zitat Lammer J, Zeller T, Hausegger KA, et al. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease). J Am Coll Cardiol. 2013;62:1320–7.CrossRefPubMed Lammer J, Zeller T, Hausegger KA, et al. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease). J Am Coll Cardiol. 2013;62:1320–7.CrossRefPubMed
7.
Zurück zum Zitat Lammer J, Zeller T, Hausegger KA, et al. Sustained benefit at 2 years for covered stents versus bare-metal stents in long SFA lesions: the VIASTAR trial. Cardiovasc Intervent Radiol. 2015;38:25–32.CrossRefPubMed Lammer J, Zeller T, Hausegger KA, et al. Sustained benefit at 2 years for covered stents versus bare-metal stents in long SFA lesions: the VIASTAR trial. Cardiovasc Intervent Radiol. 2015;38:25–32.CrossRefPubMed
8.
Zurück zum Zitat Golchehr B, Lensvelt MM, Fritschy WM, et al. Outcome of thrombolysis and thrombectomy for thrombosed endografts inserted in the superficial femoral artery for occlusive disease. J Endovasc Ther. 2013;20:836–43.CrossRefPubMed Golchehr B, Lensvelt MM, Fritschy WM, et al. Outcome of thrombolysis and thrombectomy for thrombosed endografts inserted in the superficial femoral artery for occlusive disease. J Endovasc Ther. 2013;20:836–43.CrossRefPubMed
9.
Zurück zum Zitat Vartanian SM, Johnston PC, Walker JP, et al. Clinical consequence of bare metal stent and stent graft failure in femoropopliteal occlusive disease. J Vasc Surg. 2013;58:1525–31.CrossRefPubMed Vartanian SM, Johnston PC, Walker JP, et al. Clinical consequence of bare metal stent and stent graft failure in femoropopliteal occlusive disease. J Vasc Surg. 2013;58:1525–31.CrossRefPubMed
10.
Zurück zum Zitat Pober JS, Sessa WC. Evolving functions of endothelial cells in inflammation. Nat Rev Immunol. 2007;7:803–15.CrossRefPubMed Pober JS, Sessa WC. Evolving functions of endothelial cells in inflammation. Nat Rev Immunol. 2007;7:803–15.CrossRefPubMed
11.
Zurück zum Zitat Stefanadis C, Toutouzas K, Tsiamis E, Toutouzas P. New stent design for autologous venous graft-covered stent preparation: first human application for sealing of a coronary aneurysm. Catheter Cardiovasc Interv. 2002;55:222–7.CrossRefPubMed Stefanadis C, Toutouzas K, Tsiamis E, Toutouzas P. New stent design for autologous venous graft-covered stent preparation: first human application for sealing of a coronary aneurysm. Catheter Cardiovasc Interv. 2002;55:222–7.CrossRefPubMed
12.
Zurück zum Zitat Stefanadis C, Toutouzas K, Tsiamis E, et al. Stents covered by an autologous arterial graft in porcine coronary arteries: feasibility, vascular injury and effect on neointimal hyperplasia. Cardiovasc Res. 1999;41:433–42.CrossRefPubMed Stefanadis C, Toutouzas K, Tsiamis E, et al. Stents covered by an autologous arterial graft in porcine coronary arteries: feasibility, vascular injury and effect on neointimal hyperplasia. Cardiovasc Res. 1999;41:433–42.CrossRefPubMed
13.
Zurück zum Zitat Zhuang ZW, Hoopes PJ, Koutras PC, Ebbighausen WH, Wagner RJ, Bettmann MA. Transjugular intrahepatic portosystemic shunt with an autologous vein-covered stent: results in a swine model. J Vasc Interv Radiol. 2001;12:1333–42.CrossRefPubMed Zhuang ZW, Hoopes PJ, Koutras PC, Ebbighausen WH, Wagner RJ, Bettmann MA. Transjugular intrahepatic portosystemic shunt with an autologous vein-covered stent: results in a swine model. J Vasc Interv Radiol. 2001;12:1333–42.CrossRefPubMed
14.
Zurück zum Zitat de Torre IG, Wolf F, Santos M, et al. Elastin-like recombinamer-covered stents: towards a fully biocompatible and non-thrombogenic device for cardiovascular diseases. Acta Biomater. 2015;12:146–55.CrossRefPubMed de Torre IG, Wolf F, Santos M, et al. Elastin-like recombinamer-covered stents: towards a fully biocompatible and non-thrombogenic device for cardiovascular diseases. Acta Biomater. 2015;12:146–55.CrossRefPubMed
15.
Zurück zum Zitat Shi HJ, Cao AH, Chen J, Deng G, Teng GJ. Transjugular intrahepatic portosystemic shunt with an autologous endothelial progenitor cell seeded stent: a porcine model. Acad Radiol. 2010;17:358–67.CrossRefPubMed Shi HJ, Cao AH, Chen J, Deng G, Teng GJ. Transjugular intrahepatic portosystemic shunt with an autologous endothelial progenitor cell seeded stent: a porcine model. Acad Radiol. 2010;17:358–67.CrossRefPubMed
16.
Zurück zum Zitat Shi HJ, Cao AH, Teng GJ. Seeding endothelial progenitor cells on a self-expanding metal stent: an in vitro study. J Vasc Interv Radiol. 2010;21:1061–5.CrossRefPubMed Shi HJ, Cao AH, Teng GJ. Seeding endothelial progenitor cells on a self-expanding metal stent: an in vitro study. J Vasc Interv Radiol. 2010;21:1061–5.CrossRefPubMed
17.
Zurück zum Zitat Shirota T, Yasui H, Shimokawa H, Matsuda T. Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue. Biomaterials. 2003;24:2295–302.CrossRefPubMed Shirota T, Yasui H, Shimokawa H, Matsuda T. Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue. Biomaterials. 2003;24:2295–302.CrossRefPubMed
18.
Zurück zum Zitat Mcallister TN, L’Heureux N. Tissue engineered cellular sheets, methods of making and use thereof. AC12N506FI ed: Cytograft Tissue Engineering, Inc., 2009. Mcallister TN, L’Heureux N. Tissue engineered cellular sheets, methods of making and use thereof. AC12N506FI ed: Cytograft Tissue Engineering, Inc., 2009.
19.
Zurück zum Zitat Shirota T, Yasui H, Matsuda T. Intralumenal tissue-engineered therapeutic stent using endothelial progenitor cell-inoculated hybrid tissue and in vitro performance. Tissue Eng. 2003;9:473–85.CrossRefPubMed Shirota T, Yasui H, Matsuda T. Intralumenal tissue-engineered therapeutic stent using endothelial progenitor cell-inoculated hybrid tissue and in vitro performance. Tissue Eng. 2003;9:473–85.CrossRefPubMed
20.
Zurück zum Zitat Weinandy S, Rongen L, Schreiber F, et al. The BioStent: novel concept for a viable stent structure. Tissue Eng Part A. 2012;18:1818–26.CrossRefPubMed Weinandy S, Rongen L, Schreiber F, et al. The BioStent: novel concept for a viable stent structure. Tissue Eng Part A. 2012;18:1818–26.CrossRefPubMed
21.
Zurück zum Zitat Koch S, Flanagan TC, Sachweh JS, et al. Fibrin-polylactide-based tissue-engineered vascular graft in the arterial circulation. Biomaterials. 2010;31:4731–9.CrossRefPubMed Koch S, Flanagan TC, Sachweh JS, et al. Fibrin-polylactide-based tissue-engineered vascular graft in the arterial circulation. Biomaterials. 2010;31:4731–9.CrossRefPubMed
22.
Zurück zum Zitat Gorge G, Haude M, Ge J, et al. Intravascular ultrasound after low and high inflation pressure coronary artery stent implantation. J Am Coll Cardiol. 1995;26:725–30.CrossRefPubMed Gorge G, Haude M, Ge J, et al. Intravascular ultrasound after low and high inflation pressure coronary artery stent implantation. J Am Coll Cardiol. 1995;26:725–30.CrossRefPubMed
23.
Zurück zum Zitat Romagnoli E, Sangiorgi GM, Cosgrave J, Guillet E, Colombo A. Drug-eluting stenting: the case for post-dilation. JACC Cardiovasc Interv. 2008;1:22–31.CrossRefPubMed Romagnoli E, Sangiorgi GM, Cosgrave J, Guillet E, Colombo A. Drug-eluting stenting: the case for post-dilation. JACC Cardiovasc Interv. 2008;1:22–31.CrossRefPubMed
24.
Zurück zum Zitat Fujii K, Carlier SG, Mintz GS, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol. 2005;45:995–8.CrossRefPubMed Fujii K, Carlier SG, Mintz GS, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol. 2005;45:995–8.CrossRefPubMed
25.
Zurück zum Zitat Harker LA. Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty. Am J Cardiol. 1987;60:20B–8B.CrossRefPubMed Harker LA. Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty. Am J Cardiol. 1987;60:20B–8B.CrossRefPubMed
26.
Zurück zum Zitat Faxon DP, Sanborn TA, Haudenschild CC. Mechanism of angioplasty and its relation to restenosis. Am J Cardiol. 1987;60:5B–9B.CrossRefPubMed Faxon DP, Sanborn TA, Haudenschild CC. Mechanism of angioplasty and its relation to restenosis. Am J Cardiol. 1987;60:5B–9B.CrossRefPubMed
27.
Zurück zum Zitat Karnabatidis D, Katsanos K, Siablis D. Infrapopliteal stents: overview and unresolved issues. J Endovasc Ther. 2009;16(Suppl 1):I153–62.PubMed Karnabatidis D, Katsanos K, Siablis D. Infrapopliteal stents: overview and unresolved issues. J Endovasc Ther. 2009;16(Suppl 1):I153–62.PubMed
28.
Zurück zum Zitat Curcio A, Torella D, Indolfi C. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy. Circ J. 2011;75:1287–96.CrossRefPubMed Curcio A, Torella D, Indolfi C. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy. Circ J. 2011;75:1287–96.CrossRefPubMed
29.
Zurück zum Zitat Zargham R. Preventing restenosis after angioplasty: a multistage approach. Clin Sci. 2008;114:257–64.CrossRefPubMed Zargham R. Preventing restenosis after angioplasty: a multistage approach. Clin Sci. 2008;114:257–64.CrossRefPubMed
30.
Zurück zum Zitat Kutryk MJ, Kuliszewski MA. In vivo endothelial progenitor cell seeding for the accelerated endothelialization of endovascular devices. Am J Cardiol. 2003;92:94L–5L.CrossRef Kutryk MJ, Kuliszewski MA. In vivo endothelial progenitor cell seeding for the accelerated endothelialization of endovascular devices. Am J Cardiol. 2003;92:94L–5L.CrossRef
31.
Zurück zum Zitat Vitek JJ, Roubin GS, Al-Mubarek N, New G, Iyer SS. Carotid artery stenting: technical considerations. AJNR Am J Neuroradiol. 2000;21:1736–43.PubMed Vitek JJ, Roubin GS, Al-Mubarek N, New G, Iyer SS. Carotid artery stenting: technical considerations. AJNR Am J Neuroradiol. 2000;21:1736–43.PubMed
32.
Zurück zum Zitat Ogata A, Sonobe M, Kato N, et al. Carotid artery stenting without post-stenting balloon dilatation. J Neurointerv Surg. 2014;6:517–20.CrossRefPubMed Ogata A, Sonobe M, Kato N, et al. Carotid artery stenting without post-stenting balloon dilatation. J Neurointerv Surg. 2014;6:517–20.CrossRefPubMed
33.
Zurück zum Zitat Lownie SP, Pelz DM, Lee DH, Men S, Gulka I, Kalapos P. Efficacy of treatment of severe carotid bifurcation stenosis by using self-expanding stents without deliberate use of angioplasty balloons. AJNR Am J Neuroradiol. 2005;26:1241–8.PubMed Lownie SP, Pelz DM, Lee DH, Men S, Gulka I, Kalapos P. Efficacy of treatment of severe carotid bifurcation stenosis by using self-expanding stents without deliberate use of angioplasty balloons. AJNR Am J Neuroradiol. 2005;26:1241–8.PubMed
34.
Zurück zum Zitat Maynar M, Baldi S, Rostagno R, et al. Carotid stenting without use of balloon angioplasty and distal protection devices: preliminary experience in 100 cases. AJNR Am J Neuroradiol. 2007;28:1378–83.CrossRefPubMed Maynar M, Baldi S, Rostagno R, et al. Carotid stenting without use of balloon angioplasty and distal protection devices: preliminary experience in 100 cases. AJNR Am J Neuroradiol. 2007;28:1378–83.CrossRefPubMed
35.
Zurück zum Zitat Men S, Lownie SP, Pelz DM. Carotid stenting without angioplasty. Can J Neurol Sci. 2002;29:175–9.PubMed Men S, Lownie SP, Pelz DM. Carotid stenting without angioplasty. Can J Neurol Sci. 2002;29:175–9.PubMed
36.
Zurück zum Zitat Forstermann U, Closs EI, Pollock JS, et al. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension. 1994;23:1121–31.CrossRefPubMed Forstermann U, Closs EI, Pollock JS, et al. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension. 1994;23:1121–31.CrossRefPubMed
37.
Zurück zum Zitat Ignarro LJ, Buga GM, Wei LH, Bauer PM, Wu G, del Soldato P. Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc Natl Acad Sci USA. 2001;98:4202–8.CrossRefPubMedPubMedCentral Ignarro LJ, Buga GM, Wei LH, Bauer PM, Wu G, del Soldato P. Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc Natl Acad Sci USA. 2001;98:4202–8.CrossRefPubMedPubMedCentral
Metadaten
Titel
In Vitro Quantification of Luminal Denudation After Crimping and Balloon Dilatation of Endothelialized Covered Stents
verfasst von
Shigeo Ichihashi
Frederic Wolf
Thomas Schmitz-Rode
Kimihiko Kichikawa
Stefan Jockenhoevel
Petra Mela
Publikationsdatum
18.05.2017
Verlag
Springer US
Erschienen in
CardioVascular and Interventional Radiology / Ausgabe 8/2017
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-017-1661-x

Weitere Artikel der Ausgabe 8/2017

CardioVascular and Interventional Radiology 8/2017 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.